These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34645924)

  • 1. A non-interventional study of microcirculation dynamics in allogeneic hematopoietic cell transplantation survivors compared to controls: evidence of impaired microvascular response regardless of conventional cardiovascular risk factors.
    Gavriilaki E; Anyfanti P; Sakellari I; Batsis I; Dolgyras P; Lazaridis A; Nikolaidou B; Koletsos N; Gavriilaki M; Zarifis I; Masmanidou M; Bousiou Z; Vardi A; Douma S; Anagnostopoulos A; Gkaliagkousi E
    Bone Marrow Transplant; 2022 Jan; 57(1):72-77. PubMed ID: 34645924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Endothelial Injury and Pro-Coagulant Activity Using Circulating Microvesicles in Survivors of Allogeneic Hematopoietic Cell Transplantation.
    Gavriilaki E; Sakellari I; Anyfanti P; Batsis I; Vardi A; Bousiou Z; Lazaridis A; Nikolaidou B; Zarifis I; Masmanidou M; Yiannaki E; Markala D; Anagnostopoulos A; Douma S; Gkaliagkousi E
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin microcirculation dynamics are impaired in patients with rheumatoid arthritis and no cardiovascular comorbidities.
    Anyfanti P; Gavriilaki E; Dolgyras P; Nikolaidou B; Dimitriadou A; Lazaridis A; Mastrogiannis K; Koletsos N; Triantafyllou A; Dimitroulas T; Aslanidis S; Doumas M; Douma S; Gkaliagkousi E
    Clin Exp Rheumatol; 2023 Jul; 41(7):1507-1515. PubMed ID: 36700655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.
    Bryant A; Mallick R; Huebsch L; Allan D; Atkins H; Anstee G; Sabloff M; Scrivens N; Maze D; Bredeson C; Kekre N
    Biol Blood Marrow Transplant; 2017 Dec; 23(12):2096-2101. PubMed ID: 28821454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantation.
    Saberian C; Abdel-Wahab N; Abudayyeh A; Rafei H; Joseph J; Rondon G; Whited L; Gruschkus S; Fa'ak F; Daher M; Knape C; Safa H; Shoukier M; Suarez-Almazor ME; Marcotulli M; Ludford K; Gulbis AM; Konopleva M; Ohanian M; Ravandi F; Garcia-Manero G; Oran B; Popat UR; Mehta R; Alousi AM; Daver N; Champlin R; Diab A; Al-Atrash G
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33637601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presalvage International Staging System Stage and Other Important Outcome Associations in CD34
    Bryant AR; Hilden P; Giralt S; Chung DJ; Maloy M; Landau H; Landgren O; Scordo M; Shah G; Smith EL; O'Reilly RJ; Perales MA; Koehne G
    Biol Blood Marrow Transplant; 2020 Jan; 26(1):58-65. PubMed ID: 31493537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents.
    Roeker LE; Dreger P; Brown JR; Lahoud OB; Eyre TA; Brander DM; Skarbnik A; Coombs CC; Kim HT; Davids M; Manchini ST; George G; Shah N; Voorhees TJ; Orchard KH; Walter HS; Arumainathan AK; Sitlinger A; Park JH; Geyer MB; Zelenetz AD; Sauter CS; Giralt SA; Perales MA; Mato AR
    Blood Adv; 2020 Aug; 4(16):3977-3989. PubMed ID: 32841336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse after Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma: Survival Outcomes and Factors Influencing Them.
    Chhabra S; Szabo A; Glisch C; George G; Narra RK; Harrington A; Jerkins JH; D'Souza A; Dhakal B; Pasquini MC; Hamadani M; Hari PN
    Biol Blood Marrow Transplant; 2020 Jul; 26(7):1288-1297. PubMed ID: 32135202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early versus late preemptive allogeneic hematopoietic cell transplantation for relapsed or refractory acute myeloid leukemia.
    Chen GL; Liu H; Zhang Y; Thomas J; Ross M; Wang ES; Block AW; Sait S; Deeb G; Wallace P; Wetzler M; Hahn T; McCarthy PL
    Biol Blood Marrow Transplant; 2014 Sep; 20(9):1369-74. PubMed ID: 24867777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microcirculation dynamics in systemic vasculitis: evidence of impaired microvascular response regardless of cardiovascular risk factors.
    Dolgyras P; Lazaridis A; Anyfanti P; Gavriilaki E; Koletsos N; Triantafyllou A; Nikolaidou B; Galanapoulou V; Douma S; Gkaliagkousi E
    Rheumatology (Oxford); 2023 Jul; 62(7):2510-2516. PubMed ID: 36394222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic hematopoietic cell transplantation for multiple myeloma: A retrospective analysis of the Polish Myeloma Group.
    Gołos A; Gil L; Puła B; Boguradzki P; Hałaburda K; Sawicki W; Sobczyk-Kruszelnicka M; Helbig G; Dybko J; Jurczyszyn A; Dębek S; Warzocha K; Jamroziak K
    Adv Med Sci; 2020 Sep; 65(2):429-436. PubMed ID: 32919120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial dysfunction and vascular complications after allogeneic hematopoietic cell transplantation: an expert analysis.
    Eftychidis I; Sakellari I; Anagnostopoulos A; Gavriilaki E
    Expert Rev Hematol; 2021 Sep; 14(9):831-840. PubMed ID: 34388057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leucovorin Rescue After Methotrexate Graft-Versus-Host Disease Prophylaxis Shortens the Duration of Mucositis, Time to Neutrophil Engraftment, and Hospital Length of Stay.
    Freyer CW; Gier S; Moyer ME; Berryman N; Carulli A; Ganetsky A; Timlin C; Babushok DV; Frey NV; Gill SI; Hexner EO; Loren AW; Mangan JK; Martin ME; McCurdy S; Perl AE; Smith J; Luger SM; Stadtmauer EA; Porter DL
    Transplant Cell Ther; 2021 May; 27(5):431.e1-431.e8. PubMed ID: 33965188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Pericarditis following Allogeneic Hematopoietic Cell Transplantation.
    Freyer CW; Fradley M; Madnick D; Carver JR; Frey NV; Gill SI; Ky B; Luger SM; Martin ME; McCurdy SR; O'Quinn R; Perl AE; Stadtmauer EA; Loren AW
    Transplant Cell Ther; 2021 Nov; 27(11):934.e1-934.e6. PubMed ID: 34339867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term survival among patients who are disease free at 1-year post allogeneic hematopoietic cell transplantation: a single center analysis of 389 consecutive patients.
    Solh MM; Bashey A; Solomon SR; Morris LE; Zhang X; Brown S; Holland HK
    Bone Marrow Transplant; 2018 May; 53(5):576-583. PubMed ID: 29335633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological adverse events post allogeneic hematopoietic cell transplantation: major determinants of morbidity and mortality.
    Sakellari I; Gavriilaki E; Papagiannopoulos S; Gavriilaki M; Batsis I; Mallouri D; Vardi A; Constantinou V; Masmanidou M; Yannaki E; Smias C; Geroukis T; Kazis D; Kimiskidis V; Anagnostopoulos A
    J Neurol; 2019 Aug; 266(8):1960-1972. PubMed ID: 31087160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive dental caries in patients with oral chronic graft-versus-host disease.
    Castellarin P; Stevenson K; Biasotto M; Yuan A; Woo SB; Treister NS
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1573-9. PubMed ID: 22516054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study.
    Greenfield DM; Salooja N; Peczynski C; van der Werf S; Schoemans H; Hill K; Cortelezzi A; Lupo-Stangellini M; Özkurt ZN; Arat M; Metzner B; Turlure P; Rovo A; Socié G; Mohty M; Nagler A; Kröger N; Dreger P; Labopin M; Han TS; Tichelli A; Duarte R; Basak G; Snowden JA
    Bone Marrow Transplant; 2021 Nov; 56(11):2820-2825. PubMed ID: 34274955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Graft-versus-Host Disease, Nonrelapse Mortality, and Disease Relapse in Older versus Younger Adults Undergoing Matched Allogeneic Peripheral Blood Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis.
    Bhatt VR; Wang T; Chen K; Kitko CL; MacMillan ML; Pidala JA; Al Malki MM; Badawy SM; Beitinjaneh A; Ganguly S; Hamilton B; Hildebrandt GC; Lekakis LJ; Liu H; Maziarz RT; Modi D; Murthy HS; Preussler JM; Sharma A; Spellman SR; Arora M; Lee SJ
    Transplant Cell Ther; 2022 Jan; 28(1):34-42. PubMed ID: 34637965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.